Rachael Natrajan

1 ta ish

Institute of Cancer Research

1. Resistance to therapy caused by intragenic deletion in BRCA2

   Stacey L. Edwards, Rachel Brough, Christopher J. Lord +6

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.677601